rs1443547
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004211.5(SLC6A5):c.304G>A(p.Gly102Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.355 in 1,604,384 control chromosomes in the GnomAD database, including 102,567 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_004211.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A5 | NM_004211.5 | c.304G>A | p.Gly102Ser | missense_variant | 2/16 | ENST00000525748.6 | NP_004202.4 | |
SLC6A5 | NM_001318369.2 | c.-260G>A | 5_prime_UTR_variant | 2/15 | NP_001305298.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A5 | ENST00000525748.6 | c.304G>A | p.Gly102Ser | missense_variant | 2/16 | 1 | NM_004211.5 | ENSP00000434364 | P1 | |
SLC6A5 | ENST00000298923.11 | c.304G>A | p.Gly102Ser | missense_variant, NMD_transcript_variant | 2/15 | 1 | ENSP00000298923 |
Frequencies
GnomAD3 genomes AF: 0.384 AC: 58426AN: 152068Hom.: 11654 Cov.: 34
GnomAD3 exomes AF: 0.370 AC: 83572AN: 226056Hom.: 15653 AF XY: 0.372 AC XY: 45881AN XY: 123476
GnomAD4 exome AF: 0.352 AC: 510646AN: 1452198Hom.: 90901 Cov.: 61 AF XY: 0.354 AC XY: 255810AN XY: 721666
GnomAD4 genome AF: 0.384 AC: 58448AN: 152186Hom.: 11666 Cov.: 34 AF XY: 0.382 AC XY: 28403AN XY: 74406
ClinVar
Submissions by phenotype
Hyperekplexia 3 Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Hyperekplexia Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at